Final clinical trials of a malaria vaccine, the first to reach this stage, suggest it could help protect millions of children against malaria.
Data from the trial published in journal, The Lancet, showed the drug RTS-S protected about one-third of children vaccinated. Malaria kills more than half-a-million children a year, mainly in Africa. There is currently no licensed vaccine against malaria anywhere in the world.